ITMI20041569A1 - "ligandi peptidici specifici per le immunoglobuline" - Google Patents

"ligandi peptidici specifici per le immunoglobuline"

Info

Publication number
ITMI20041569A1
ITMI20041569A1 IT001569A ITMI20041569A ITMI20041569A1 IT MI20041569 A1 ITMI20041569 A1 IT MI20041569A1 IT 001569 A IT001569 A IT 001569A IT MI20041569 A ITMI20041569 A IT MI20041569A IT MI20041569 A1 ITMI20041569 A1 IT MI20041569A1
Authority
IT
Italy
Prior art keywords
amino acid
residue
tyr
configuration
cys
Prior art date
Application number
IT001569A
Other languages
English (en)
Inventor
Piero Bellofiore
Giovanni Cassani
Daniela Marasco
Simona Monti
Carlo Pedone
Menotti Ruvo
Antonio Verdoliva
Original Assignee
Tecnogen Scpa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecnogen Scpa filed Critical Tecnogen Scpa
Priority to IT001569A priority Critical patent/ITMI20041569A1/it
Publication of ITMI20041569A1 publication Critical patent/ITMI20041569A1/it
Priority to DE602005010634T priority patent/DE602005010634D1/de
Priority to ES05076751T priority patent/ES2315787T3/es
Priority to EP05076751A priority patent/EP1621546B1/en
Priority to AT05076751T priority patent/ATE412660T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • HELECTRICITY
    • H04ELECTRIC COMMUNICATION TECHNIQUE
    • H04BTRANSMISSION
    • H04B1/00Details of transmission systems, not covered by a single one of groups H04B3/00 - H04B13/00; Details of transmission systems not characterised by the medium used for transmission
    • H04B1/38Transceivers, i.e. devices in which transmitter and receiver form a structural unit and in which at least one part is used for functions of transmitting and receiving
    • H04B1/3827Portable transceivers
IT001569A 2004-07-30 2004-07-30 "ligandi peptidici specifici per le immunoglobuline" ITMI20041569A1 (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IT001569A ITMI20041569A1 (it) 2004-07-30 2004-07-30 "ligandi peptidici specifici per le immunoglobuline"
DE602005010634T DE602005010634D1 (de) 2004-07-30 2005-07-28 Peptidische Ligande die eine spezifische Bindungsfähigkeit für Immunoglobuline zeigen
ES05076751T ES2315787T3 (es) 2004-07-30 2005-07-28 Ligandos peptidicos especificos para las inmunoglobulinas.
EP05076751A EP1621546B1 (en) 2004-07-30 2005-07-28 Peptide ligands specific to immonoglobulins
AT05076751T ATE412660T1 (de) 2004-07-30 2005-07-28 Peptidische ligande die eine spezifische bindungsfähigkeit für immunoglobuline zeigen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001569A ITMI20041569A1 (it) 2004-07-30 2004-07-30 "ligandi peptidici specifici per le immunoglobuline"

Publications (1)

Publication Number Publication Date
ITMI20041569A1 true ITMI20041569A1 (it) 2004-10-30

Family

ID=34956524

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001569A ITMI20041569A1 (it) 2004-07-30 2004-07-30 "ligandi peptidici specifici per le immunoglobuline"

Country Status (5)

Country Link
EP (1) EP1621546B1 (it)
AT (1) ATE412660T1 (it)
DE (1) DE602005010634D1 (it)
ES (1) ES2315787T3 (it)
IT (1) ITMI20041569A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100004316A1 (en) * 2006-09-29 2010-01-07 University Of Utah Research Foundation Multifunctional carriers for the delivery of nucleic acids and methods of use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439829A (en) * 1991-01-30 1995-08-08 Eli Lilly And Company Immobilization of biologically active molecules by changing the Oxidation state of a chelated transition metal ion
ATE185147T1 (de) 1995-06-21 1999-10-15 Tecnogen Scpa Peptidliganden für die konstante region von immunoglobulinen
US6469153B1 (en) * 1998-05-20 2002-10-22 The Trustees Of Columbia University In The City Of New York EIP-1 and EIP-3 genes, envelope-interacting proteins, EIP-1 and EIP-3
DE19913707A1 (de) * 1999-03-26 2000-10-05 Privates Inst Bioserv Gmbh Immunadsorber zur Sepsistherapie
CA2290722A1 (en) * 1999-12-08 2001-06-08 Glen C. Macdonald Consensus peptide presenting entities
EP1334442A2 (en) * 2000-11-06 2003-08-13 Thrasos, Inc. Computer method and apparatus for classifying objects
WO2002059340A1 (en) * 2001-01-26 2002-08-01 The Scripps Research Institute Immunopolypeptides to hepatitis c virus
DE60227519D1 (de) * 2001-06-14 2008-08-21 Takeda Pharmaceutical Neuer ligand und dna davon
US20030113322A1 (en) * 2001-12-18 2003-06-19 Cedric Bes CDR-H1-derived peptide CB11, pharmaceutical compositions made therefrom and methods of treating disorders in mammals
RU2206573C1 (ru) * 2001-12-27 2003-06-20 Институт молекулярной генетики РАН Семейство пептидов, обладающих нейротропными свойствами
AU2003222069A1 (en) * 2002-03-29 2003-10-20 Centocor, Inc. Mammalian cdr mimetibodies, compositions, methods and uses
JP4612270B2 (ja) * 2002-06-27 2011-01-12 靖一 田沼 生理活性ペプチドの設計法及びその用途
EP1479764A1 (en) * 2003-05-19 2004-11-24 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Heparanase-derived peptides for vaccination of tumor patients

Also Published As

Publication number Publication date
EP1621546A1 (en) 2006-02-01
DE602005010634D1 (de) 2008-12-11
EP1621546B1 (en) 2008-10-29
ATE412660T1 (de) 2008-11-15
ES2315787T3 (es) 2009-04-01

Similar Documents

Publication Publication Date Title
DE60026875D1 (de) Zink-aminosäure-chelate mit glyzin und einer schwefelhaltigen aminosäure als liganden
CY1113684T1 (el) Anti-mikρobiaka πεπτιδια που περιλαμβανουν μια αργινινη (arginine)- kai/ή λυσινη (lysine)- που περιεχουν υποκινητη
HRP20161614T1 (hr) Terapijska sredstva za smanjenje razina paratiroidnog hormona
RU2002127470A (ru) Стабилизирующий состав
MXPA05014198A (es) Activos antitranspirantes de aluminio/zirconio/glicina estabilizados con betaina.
PL344599A1 (en) Novel cyclosporins
PT2360176E (pt) Expressão híbrida e em série de proteínas derivadas de neisseria
DE3784799D1 (de) Malonsaeurederivate und ihre synthesemethoden.
DE60221508D1 (de) Aminosäurederivate als hiv-protease-inhibitoren
SI1483246T1 (sl) 5-substituirani alkilaminopirazolni derivati kot pesticidi
ITMI20041569A1 (it) "ligandi peptidici specifici per le immunoglobuline"
DE60331051D1 (de) Neue atorvastatinsalze und pharmazeutische zusammensetzungen, die diese enthalten
MX2009002962A (es) Peptidos antibacterianos y antivirales de actinomadura namibiensis.
MXPA03007622A (es) Peptidos a partir del anticuerpo 16/6id para tratar lupus eritematoso sistemico.
DE60209215D1 (de) Zusammensetzungen mit verbesserter farbstabilität die leucine enthalten
WO2011125040A3 (en) New polyterpene type compounds, compositions containing them and topical uses thereof
SE0100949L (sv) Jordbruks- och trädgårdskomposition
ATE271054T1 (de) Herstellung von metallkomplexen von aminosäuren, hergestellt durch hydrolyse von sojaprotein
WO2001064715A3 (en) Memno peptides, a process for their preparation and their use
ATE525369T1 (de) Herstellung von 2',6'-dipyrazolylpyridin mit einer reaktiven r-gruppe in position 4
RU2229897C2 (ru) Бактерициды на основе хелатных комплексов металлов
WO2002030874A3 (en) Aliphatic, cyclic amino carboxylic acids as integrin antagonists
WO2002048178A3 (en) Cyclophilin-binding ligands
WO2002042413A3 (en) Methods and compositions involved in groucho-mediated differentiation
RS81704A (en) Dipyridodiazepinones as reverse transcritase inhibitors